206 related articles for article (PubMed ID: 26300063)
21. Therapy-related acute leukemia with mixed phenotype and t(9;22)(q32;q11.2): a case report and review of the literature.
Cho JH; Hur M; Moon HW; Yun YM; Ko YS; Kim WS; Lee MH
Hum Pathol; 2012 Apr; 43(4):605-9. PubMed ID: 22036054
[TBL] [Abstract][Full Text] [Related]
22. Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemia.
Todisco E; Testi AM; Avvisati G; Moleti ML; Cedrone M; Cimino G; Mancini F; Amadori S; Mandelli F
Leukemia; 1995 Sep; 9(9):1583-5. PubMed ID: 7658728
[TBL] [Abstract][Full Text] [Related]
23. Unusual findings of acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): A multicenter study.
Gong X; Yu T; Tang Q; Fu Y; Wu J; Zhu Y; Tu H; Ge H; Lu X; Gong D; Zhao X
Int J Lab Hematol; 2019 Jun; 41(3):380-386. PubMed ID: 30793839
[TBL] [Abstract][Full Text] [Related]
24. High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities.
Ishizawa S; Slovak ML; Popplewell L; Bedell V; Wrede JE; Carter NH; Snyder DS; Arber DA
Leukemia; 2003 Jun; 17(6):1091-5. PubMed ID: 12764373
[TBL] [Abstract][Full Text] [Related]
25. A t(4;11)(q21;p15) in a case of T-cell lymphoma and a case of acute myelogenous leukemia.
Thangavelu M; Huang B; Lemieux M; Tom W; Richkind KE
Cancer Genet Cytogenet; 2002 Jan; 132(2):109-15. PubMed ID: 11850070
[TBL] [Abstract][Full Text] [Related]
26. t(3;8)(q26.2;q24) Often Leads to MECOM/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression.
Tang G; Hu S; Wang SA; Xie W; Lin P; Xu J; Toruner G; Zhao M; Gu J; Doty M; Li S; Medeiros LJ; Tang Z
J Mol Diagn; 2019 Mar; 21(2):343-351. PubMed ID: 30576868
[TBL] [Abstract][Full Text] [Related]
27. MYC Amplification in the Form of Ring Chromosomes 8 in Acute Myeloid Leukemia with t(11;16)(q13;p11.2).
Yamamoto K; Kawamoto S; Kurata K; Kitao A; Mizutani Y; Ichikawa H; Yakushijin K; Kajimoto K; Hayashi Y; Matsuoka H; Minami H
Cytogenet Genome Res; 2017; 153(3):131-137. PubMed ID: 29393095
[TBL] [Abstract][Full Text] [Related]
28. Acute myelogenous leukemia with the t(3;12)(q26;p13) translocation: case report and review of the literature.
Voutsadakis IA; Maillard N
Am J Hematol; 2003 Feb; 72(2):135-7. PubMed ID: 12555218
[TBL] [Abstract][Full Text] [Related]
29. Development of a dual-color, double fusion FISH assay to detect RPN1/EVI1 gene fusion associated with inv(3), t(3;3), and ins(3;3) in patients with myelodysplasia and acute myeloid leukemia.
Shearer BM; Sukov WR; Flynn HC; Knudson RA; Ketterling RP
Am J Hematol; 2010 Aug; 85(8):569-74. PubMed ID: 20556821
[TBL] [Abstract][Full Text] [Related]
30. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
31. Acute myeloid leukaemia with t(9;11)(p22;q23) in a patient treated for adult T cell leukaemia.
Nakamura H; Ishizaki T; Itoyama T; Soda H; Yoshida Y; Yamada Y; Kuriyama K; Sadamori N; Tomonaga M
Br J Haematol; 1994 Jan; 86(1):222-4. PubMed ID: 8011538
[TBL] [Abstract][Full Text] [Related]
32. Therapy-related leukemia with a novel 21q22 rearrangement.
Izumi T; Ohtsuki T; Ohya K; Ogawa Y; Yoshida M; Muroi K; Imagawa S; Hatake K; Kuriki K; Saito K; Miura Y
Cancer Genet Cytogenet; 1996 Aug; 90(1):45-8. PubMed ID: 8780746
[TBL] [Abstract][Full Text] [Related]
33. The t(14;18)(q32;q21) with extra MYC signal - is it a gray zone lymphoma?
Chang QA; Qasem A; Madhusudhana S; Glazyrin A
Int J Clin Exp Pathol; 2015; 8(8):9602-8. PubMed ID: 26464726
[TBL] [Abstract][Full Text] [Related]
34. [Primary ocular adnexal lymphoproliferative lesions: clinicopathologic features and genetic alterations].
Dong LN; Liu HG; Jin HS; Ye HT; Gao ZF; Zhou XG; Dong GH; Zhang DD; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2008 Dec; 37(12):809-14. PubMed ID: 19159526
[TBL] [Abstract][Full Text] [Related]
35. [Therapy-related AML(M2) with t(8;21) that developed three years after chemotherapy for hepatocellular carcinoma].
Miyata A; Deguchi S; Fujita M; Kikuchi T; Honda K
Rinsho Ketsueki; 1996 May; 37(5):448-51. PubMed ID: 8691593
[TBL] [Abstract][Full Text] [Related]
36. Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome.
Li S; Yin CC; Medeiros LJ; Bueso-Ramos C; Lu G; Lin P
Am J Clin Pathol; 2012 Jul; 138(1):146-52. PubMed ID: 22706870
[TBL] [Abstract][Full Text] [Related]
37. [Malignant lymphoma with c-myc gene rearrangement in a patient receiving long-term treatment for multiple myeloma].
Ohnishi H; Kamimura T; Gondo H; Okamura T; Niho Y; Yao T
Rinsho Ketsueki; 1999 Dec; 40(12):1265-70. PubMed ID: 10658480
[TBL] [Abstract][Full Text] [Related]
38. Spectral karyotyping and fluorescence in situ hybridization analyses identified a novel three-way translocation involving inversion 16 in therapy-related acute myeloid leukemia M4eo.
Ohsaka A; Otsubo K; Yokota H; Hisa T; Saito H; Kozaki T
Cancer Genet Cytogenet; 2008 Jul; 184(2):113-8. PubMed ID: 18617061
[TBL] [Abstract][Full Text] [Related]
39. Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia.
Cui W; Sun J; Cotta CV; Medeiros LJ; Lin P
Am J Clin Pathol; 2011 Aug; 136(2):282-8. PubMed ID: 21757602
[TBL] [Abstract][Full Text] [Related]
40. Molecular cytogenetics reveals complex karyotype in apparent t(8;13) therapy-related acute myeloid leukemia M2 after fibrosarcoma.
Soares-Ventura EM; Mkrtchyan H; de Jesus Marques-Salles T; Silva M; Santos N; de Araujo Silva Amaral B; Liehr T; Abdelhay E; Silva ML; Muniz MT
Leuk Res; 2011 May; 35(5):e27-9. PubMed ID: 21329977
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
